TY  - JOUR
T1  - THe purity of cholestyramine resin-reply
AU  - Fox EJ
Y1  - 1989/12/08
N1  - 10.1001/jama.1989.03430220048012
JO  - JAMA
SP  - 3127
EP  - 3128
VL  - 262
IS  - 22
N2  - In Reply. — 
    We are pleased to respond to the questions about Questran raised by Dr Goldstein by assuring him that (1) the cholestyramine resin used in the Lipid Research Clinics Coronary Primary Prevention Trial (LRC-CPPT) was not contaminated, (2) currently marketed Questran is free of contamination, and (3) although a temporal association between cholestyramine resin and certain tumors has been observed, a causal relationship has not been established after more than 20 years of commercial availability and several hundred thousand patient-years of therapy dispensed.The questions asked by Dr Goldstein appear to arise from the fact that, in April 1988, Bristol Laboratories initiated a recall because it determined that certain batches of bulk cholestyramine resin supplied by Rohm & Haas and used in the production of Questran contained very low levels of the agricultural chemicals dichlorodiphenyldichloroethylene and dichlorobenzophenone. These chemicals are related to the manufacture of a pesticide (dicofol)
SN  - 0098-7484
M3  - doi: 10.1001/jama.1989.03430220048012
UR  - http://dx.doi.org/10.1001/jama.1989.03430220048012
ER  -